Work

Abstract CT090: Rational design of an oncolytic virus permits use of interferon beta as a pharmacodynamic marker for clinical application

Year: 2019

Type: conference-abstract

Source: Clinical Trials

DOI: 10.1158/1538-7445.sabcs18-ct090

Authors: Timothy P. Cripe, Jamie Bakkum-Gamez, Jaime R. Merchan, Martha Q. Lacy, Manish R. Patel, Steven Powell, James Strauss, Lianwen Zhang, Toshie Sakuma, Memy Diaz, Nandakumar Packiriswamy, Deepak Upreti, Bethany Brunton, Dragan Jevremovic, Stephen J. Russell, Alice Bexon, Kah-Whye Peng

Institutions: Nationwide Children's Hospital, Mayo Clinic, University of Miami, University of Minnesota, Sanford Health, Mary Crowley Cancer Research Center

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2955070993

Cites:

Cited by:

Related to: 10